Sergi M et al. |
Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS. |
2013 |
Anal Bioanal Chem |
pmid:22847477
|
Ueda N et al. |
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. |
2013 |
FEBS J. |
pmid:23425575
|
Sugaya Y et al. |
The endocannabinoid 2-arachidonoylglycerol negatively regulates habituation by suppressing excitatory recurrent network activity and reducing long-term potentiation in the dentate gyrus. |
2013 |
J. Neurosci. |
pmid:23426686
|
DiPatrizio NV et al. |
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. |
2013 |
FASEB J. |
pmid:23463697
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Jain T et al. |
Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. |
2013 |
Mol. Pharmacol. |
pmid:23748223
|
Signorello MG et al. |
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets. |
2013 |
Biochimie |
pmid:23702422
|
Higgins A et al. |
Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids. |
2013 |
Mol Pain |
pmid:23725095
|
Almeida-Santos AF et al. |
Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. |
2013 |
Behav. Brain Res. |
pmid:23714073
|
Perez-Rosello T et al. |
Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis. |
2013 |
J. Neurosci. |
pmid:23719795
|
Yang Y et al. |
Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. |
2013 |
Cell. Signal. |
pmid:23142606
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
Starowicz K et al. |
Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. |
2013 |
PLoS ONE |
pmid:23573230
|
Subbanna S et al. |
Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. |
2013 |
J. Neurosci. |
pmid:23575834
|
Morgan CJ et al. |
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. |
2013 |
Br J Psychiatry |
pmid:23580381
|
Blankman JL and Cravatt BF |
Chemical probes of endocannabinoid metabolism. |
2013 |
Pharmacol. Rev. |
pmid:23512546
|
Ikeda H et al. |
Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. |
2013 |
Neuroscience |
pmid:23892011
|
Yuan S and Burrell BD |
Nonnociceptive afferent activity depresses nocifensive behavior and nociceptive synapses via an endocannabinoid-dependent mechanism. |
2013 |
J. Neurophysiol. |
pmid:24027102
|
Blasio A et al. |
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. |
2013 |
Neuropsychopharmacology |
pmid:23793355
|
Baur R et al. |
Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β₂ subunit of GABA(A) receptors. |
2013 |
J. Neurochem. |
pmid:23600744
|